Phase 1/2 study of zilovertamab vedotin in pediatric and young adult hematologic malignancies or solid tumors (LIGHTBEAM-U01A).

Authors: Hyoung Jin Kang, Pablo Berlanga, Quentin Campbell-Hewson, Steven G. DuBois, Kyung-Nam Koh, Christine Mauz-Körholz, Michael James Sullivan, David Mangum, Rachael Windsor, David S. Dickens, Alexandre Duarte, Farzana D. Pashankar, Shifra Ash, Andrew Joseph Bellantoni, Scott J. Diede, Rohini Singh, Yulia Sidi, Michal Yalon

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps10075

Source: Full article

---

Abstract

TPS10075